AAAAAA

   
Results: 1-8 |
Results: 8
GASTRIC-EMPTYING IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUSAND BIOAVAILABILITY OF THIOCTIC ACID-ENANTIOMERS
Authors: HERMANN R WILDGRUBE HJ RUUS P NIEBCH G NOWAK H GLEITER CH
Citation: R. Hermann et al., GASTRIC-EMPTYING IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUSAND BIOAVAILABILITY OF THIOCTIC ACID-ENANTIOMERS, European journal of pharmaceutical sciences, 6(1), 1998, pp. 27-37
SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF THEGONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX IN HEALTHY FEMALE VOLUNTEERS
Authors: DUIJKERS IJM KLIPPING C WILLEMSEN WNP KRONE D SCHNEIDER E NIEBCH G ROMEIS P HERMANN R
Citation: Ijm. Duijkers et al., SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF THEGONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX IN HEALTHY FEMALE VOLUNTEERS, Human reproduction (Oxford. Print), 13, 1998, pp. 239-239
ENANTIOSELECTIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY OF (-ALPHA-LIPOIC AND (-)S-ALPHA-LIPOIC ACID IN HUMAN PLASMA()R)
Authors: NIEBCH G BUCHELE B BLOME J GRIEB S BRANDT G KAMPA P RAFFEL HH LOCHER M BORBE HO NUBERT I FLEISCHHAUER I
Citation: G. Niebch et al., ENANTIOSELECTIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY OF (-ALPHA-LIPOIC AND (-)S-ALPHA-LIPOIC ACID IN HUMAN PLASMA()R), Chirality, 9(1), 1997, pp. 32-36
ENANTIOSELECTIVE PHARMACOKINETICS AND BIOAVAILABILITY OF DIFFERENT RACEMIC ALPHA-LIPOIC ACID FORMULATIONS IN HEALTHY-VOLUNTEERS
Authors: HERMANN R NIEBCH G BORBE HO FIEGERBUSCHGES H RUUS P NOWAK H RIETHMULLERWINZEN H PEUKERT M BLUME H
Citation: R. Hermann et al., ENANTIOSELECTIVE PHARMACOKINETICS AND BIOAVAILABILITY OF DIFFERENT RACEMIC ALPHA-LIPOIC ACID FORMULATIONS IN HEALTHY-VOLUNTEERS, European journal of pharmaceutical sciences, 4(3), 1996, pp. 167-174
CLINICAL-PHASE-I AND PHARMACOKINETIC TRIAL OF THE NEW TITANIUM COMPLEX BUDOTITANE
Authors: SCHILLING T KEPPLER KB HEIM ME NIEBCH G DIETZFELBINGER H RASTETTER J HANAUSKE AR
Citation: T. Schilling et al., CLINICAL-PHASE-I AND PHARMACOKINETIC TRIAL OF THE NEW TITANIUM COMPLEX BUDOTITANE, Investigational new drugs, 13(4), 1995, pp. 327-332
PHARMACOKINETICS OF NAFTOPIDIL, A NOVEL ANTIHYPERTENSIVE DRUG, IN PATIENTS WITH HEPATIC-DYSFUNCTION
Authors: FARTHING MJG ALSTEAD EM ABRAMS SML HAUG G JOHNSTON A HERMANN R NIEBCH G RUUS P MOLZ KH TURNER P
Citation: Mjg. Farthing et al., PHARMACOKINETICS OF NAFTOPIDIL, A NOVEL ANTIHYPERTENSIVE DRUG, IN PATIENTS WITH HEPATIC-DYSFUNCTION, Postgraduate medical journal, 70(823), 1994, pp. 363-366
NAFTOPIDIL INHIBITS 5-HYDROXYTRYPTAMINE-INDUCED PLATELET-AGGREGATION AND 5-HYDROXYTRYPTAMINE UPTAKE IN PLATELETS OF HEALTHY-VOLUNTEERS
Authors: KIRSTEN R BREIDERT M NELSON K HEINE A ROSENKRANZ S ERDEG B NIEBCH G BORBE HO SIEBERTWEIGEL M RESPONDEK J
Citation: R. Kirsten et al., NAFTOPIDIL INHIBITS 5-HYDROXYTRYPTAMINE-INDUCED PLATELET-AGGREGATION AND 5-HYDROXYTRYPTAMINE UPTAKE IN PLATELETS OF HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 46(3), 1994, pp. 271-274
SYNTHESIS OF POTENTIAL NAFTOPIDIL METABOL ITES
Authors: KUTSCHER B ENGEL J FLEISCHHAUER I NIEBCH G
Citation: B. Kutscher et al., SYNTHESIS OF POTENTIAL NAFTOPIDIL METABOL ITES, Archiv der pharmazie, 326(10), 1993, pp. 803-806
Risultati: 1-8 |